abnormal B cell physiology_Sphk2<tm1Npa>/Sphk2<tm1Npa>

http://metadb.riken.jp/0002459BALBcSphk2tm1NpaSphk2tm1NpaSphk2tm1NpaSphk2tm1Npa

abnormal B cell physiology_Sphk2<tm1Npa>/Sphk2<tm1Npa>

表現型アノテーション

MGI marker

http://metadb.riken.jp/db/mgi_rdf/variant_of

• sphingosine kinase 2
  http://metadb.riken.jp/db/mgi_rdf/MGI:1861380

遺伝子型

http://metadb.riken.jp/db/mgi_rdf/allele_composition

• Sphk2<tm1Npa>/Sphk2<tm1Npa>

アレルシンボル

http://metadb.riken.jp/db/mgi_rdf/allele_symbol

• Sphk2<tm1Npa>

遺伝的背景

http://metadb.riken.jp/db/mgi_rdf/genetic_background

• BALB/c-Sphk2<tm1Npa>

MP annotation

http://metadb.riken.jp/db/bioresource_schema/brs_indicatesPhenotype

• abnormal B cell physiology
  http://purl.obolibrary.org/obo/MP_0002459

文献

http://purl.org/net/cito/citesAsAuthority

• Barbara. Zemann, et.al., Sphingosine kinase type 2 is essential for lymphopenia induced by the immunomodulatory drug FTY720., Blood, 2006, 107
  http://rdf.ncbi.nlm.nih.gov/pubmed/16223773